Related Experiment Video
Updated: May 15, 2026
10:14
Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Spectral domain OCT to diagnose clinically inapparent hypotony maculopathy using 3D image rendering software.
Muhammad Raja1, Stavoroula Boukavala, Craig Goldsmith
1Department of Ophthalmology, James Paget University Hospital NHS Foundation Trust, Great Yarmouth, Norfolk, UK. docraja@hotmail.com
BMJ Case Reports
|December 25, 2012
Summary
Diagnosing subclinical hypotony maculopathy, especially in eyes with cataracts, is challenging. Spectral domain optical coherence tomography (OCT) aids in identifying this condition and monitoring treatment effectiveness.
Area of Science:
- Ophthalmology
- Medical Imaging
Background:
- Hypotony maculopathy can present subtly, posing diagnostic challenges, particularly in eyes with significant cataracts or cloudy ocular media.
- Accurate diagnosis is crucial for effective management and preventing vision loss.
Observation:
- A case of subclinical hypotony maculopathy in an only-eyed patient with a dense cataract was investigated.
- Three-dimensional (3D) imaging from a commercial optical coherence tomogram (OCT) system was utilized for diagnosis.
Findings:
- Spectral domain OCT successfully visualized subtle macular changes indicative of hypotony maculopathy, despite the dense cataract.
- Post-bleb revision surgery, improved intraocular pressure and symptom resolution were confirmed by repeat OCT imaging.
Implications:
- Spectral domain OCT is a valuable tool for diagnosing subclinical hypotony maculopathy in complex ocular conditions.
- This technology can aid in timely intervention and improved patient outcomes, even with compromised ocular media.
